Neuronetics Q3 EPS $(0.33) Misses $(0.31) Estimate, Sales $17.88M Beat $17.58M Estimate
Portfolio Pulse from Benzinga Newsdesk
Neuronetics reported Q3 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 17.86 percent decrease over losses from the same period last year. However, the company's quarterly sales of $17.88 million beat the analyst consensus estimate of $17.58 million by 1.73 percent, marking an 8.40 percent increase over sales from the same period last year.
November 07, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Neuronetics reported a larger than expected Q3 loss but beat sales estimates. This mixed result could lead to uncertainty in the market.
Neuronetics reported a larger than expected loss for Q3, which is negative for the stock. However, the company also reported higher than expected sales, which is positive. The mixed results could lead to uncertainty in the market, making it difficult to predict the short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100